Letter to the Editors: Statins and COVID-19: Efficacy Still to Be Proven

Clicks: 282
ID: 115221
2020
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #11 of 13 articles by views in Hepatology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
We read with interest the article by Bloom et al reporting liver biochemistry-associated trends, etiologies, and outcomes in 60 patients with coronavirus disease 2019 (COVID-19). The authors reported that 69% of the patients had abnormal liver function tests (LFTs) on admission and 93% during their …
Reference Key
l2020hepatologyletter Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Meunier L;Meszaros M;Pageaux GP;;
Journal Hepatology
Year 2020
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/32767854
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE pubmed abstract nih national institutes of health national library of medicine letter pmid:32767854 pmc7436210 doi:10.1002/hep.31511 lucy meunier magdalena meszaros georges-philippe pageaux

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.